IL22 and arthritic joint disease: Our finding that neutralizing anti–IL‐22 antibodies could prevent both ES‐62–mediated desensitization of synovial fibroblast responses and protection against CIA strongly suggests that IL‐22 has a role in desensitizing synovial fibroblasts and promoting resolution of joint inflammation in established arthritis.